ClassID:

20501

A61K31/664 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Phosphorus compounds Amides of phosphorus acids

Recent Application in this class:
#301
20100062053
2010-03-11

Cholestanol derivative for combined use

#302
20100056825
2010-03-04

Formulations of canfosfamide and their preparation

#303
20100048499
2010-02-25

Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane

#304
20090246197
2009-10-01

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)

#305
20090216022
2009-08-27

Cyclopamine analogs

#306
20090136494
2009-05-28

Combination therapies employing GITR binding molecules

#307
20090012109
2009-01-08

Cyclopamine analogs

#308
20080293754
2008-11-27

Cyclopamine analogs

#309
20080267945
2008-10-30

Salts of isophosphoramide mustard and analogs thereof as anti-tumor Agents

#310
20080255056
2008-10-16

Salts of isophosphoramide mustard and analogs thereof

#311
20080242638
2008-10-02

Induction of differential stress resistance and uses thereof

#312
20080131495
2008-06-05

Mucinous glycoprotein (MUC-1) vaccine

#313
20080125400
2008-05-29

USE OF PHOSPHOENOLPYRUVATE DERIVATIVES

#314
20080119450
2008-05-22

Use of creatine or creatine analogs for the treatment of diseases of the nervous system

#315
20080096922
2008-04-24

Novel Sulfonamide derivative

#316
20070287685
2007-12-13

Medicinal composition containing FBPase inhibitor

#317
20070270388
2007-11-22

Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid

#318
20070041956
2007-02-22

Vaccine immunotherapy for immune suppressed patients

#319
20060223760
2006-10-05

Compositions and methods for treatment of cancer

#320
20060178338
2006-08-10

Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs

#321
20060127482
2006-06-15

Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases

#322
20060089333
2006-04-27

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

#323
20050197321
2005-09-08

Treatment of sepsis

#324
20050152874
2005-07-14

Vaccine immunotherapy for immune suppressed patients

#325
20050079144
2005-04-14

Method for decreasing sebum production

#326
17320388
2022-05-17

Compositions and methods for treating leber's hereditary optic neuropathy

#327
17099293
2023-07-04

Neuroprotective mixture for mitigating the harmful effects of ischemic stroke

#328
15911009
2018-10-30

Method of preparing biologically active derivatives from flowers

#329
13552920
2017-01-24

Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvination